from Genentech and Cambridge, Massachusetts–based Biogen Idec, which also recently gained marketing approval for CLL. Arzerra, though, binds a different epitope on the B-cell CD20 antigen ...

A European regulatory committee now recommends approval of the Alzheimer’s treatment lecanemab a few months after rejecting ...

A European regulatory committee now recommends approval of the Alzheimer’s treatment lecanemab a few months after rejecting ...

Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and (Nasdaq: BIIB, Corporate headquarters: Cambridge, ...

INCHEON, South Korea and CAMBRIDGE, MA, USA I November 18, 2024 I Samsung Bioepis Co., Ltd. and Biogen Inc. (Nasdaq: BIIB) today announced that the European ...

Needham has downgraded Biogen (BIIB) to hold from buy, citing a lack of near-term catalysts and slow uptake for the company’s ...

Needham analyst Ami Fadia downgraded Biogen (BIIB) to Hold from Buy.Don't Miss our Black Friday Offers:Discover the latest stocks recommended ...

Needham downgraded Biogen (BIIB) to Hold from Buy without a price target The firm does not see a meaningful source of upside for the shares ...

Cambridge and Allston voters sent nine uncontested ... The results in the uncontested race come even as Massachusetts voters are viewing the notoriously opaque State House with increased scrutiny.

the Alzheimer's disease drug it developed in partnership with Eisai Inc. The Cambridge biotech said it's increasing its 2024 financial guidance in its third-quarter earnings on Wednesday. Biogen ...

Community Charter School of Cambridge is a charter school located in Cambridge, MA, which is in a mid-size city setting. The student population of Community Charter School of Cambridge is 253 and ...

Kennedy, an anti-vaccine activist, reportedly said Trump had “promised” him “control” of the country’s public health agencies ...